Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101
Sponsor: Poseida Therapeutics, Inc.
Summary
Subjects are enrolled in this study following completion or early discontinuation from a Poseida sponsored or supported study of P-BCMA-101 T cells and will be followed for a total of 15 years post treatment from the last P-BCMA-101 treatment. Subjects will be monitored for safety and efficacy to assess the risk of delayed adverse events (AEs) and assess long-term efficacy, and PK and quantification of P-BCMA-101 T cells. Rimiducid may be administered as indicated.
Official title: Open Label, Multicenter, Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2018-10-29
Completion Date
2032-11
Last Updated
2026-03-04
Healthy Volunteers
No
Conditions
Interventions
Rimiducid may be administered as indicated
Patients who received P-BCMA-101 in a previous trial will be evaluated in this trial for long term safety and efficacy. Rimiducid (safety switch activator) may be administered as indicated.
Locations (13)
University of California Davis
Davis, California, United States
University of California, San Diego
San Diego, California, United States
University of California San Francisco
San Francisco, California, United States
Colorado Blood Cancer Institute
Denver, Colorado, United States
University of Chicago
Chicago, Illinois, United States
University of Kansas Cancer Center
Westwood, Kansas, United States
University of Maryland Greenebaum Comprehensive Cancer Center
Baltimore, Maryland, United States
Johns Hopkins University
Baltimore, Maryland, United States
Wayne State - Karmanos Cancer Institute
Detroit, Michigan, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Sarah Cannon Research Institute at Tennessee Oncology
Nashville, Tennessee, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
MD Anderson Cancer Center
Houston, Texas, United States